StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Qiagen's price to sales ratio was 5.3× on Nov 11, 2026, against 5.7× a year earlier. Over the last 5 years it ranged from 3.6× to 7.3×, with a median of 5.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.3×−0.1
2025Dec 31, 20255.4×+0.2
2024Dec 31, 20245.2×+0.3
2023Dec 29, 20234.9×−0.5
2022Dec 30, 20225.4×−1.9
2021Dec 31, 20217.3×−0.9
2020Dec 31, 20208.3×+2.7
2019Dec 31, 20195.5×−0.4
2018Dec 31, 20186.0×+0.1
2017Dec 29, 20175.8×+0.3
2016Dec 30, 20165.5×+0.2
2015Dec 31, 20155.3×+0.7
2014Dec 31, 20144.6×−0.1
2013Dec 31, 20134.7×+0.9
2012Dec 31, 20123.8×+3.8
2011Dec 30, 20110.0×−4.7
2010Dec 31, 20104.7×−0.6
2009Dec 31, 20095.4×–

More Qiagen figures

See a number that looks wrong?